Main> Viagra> Iv infusion rate of phenergan

Iv infusion rate of phenergan

Phenergan, Phenadoz promethazine dosing, indications. DO NOT GIVE IV PUSH - MUST DILUTE FIRST AND ADMINISTER BY SLOW IV INFUSION- SEE BELOW. Subcutaneous or intra-arterial injection is contraindicated as these routes of administration may cause tissue necrosis and gangrene of the affected extremity, respectively (Prod Info Phenergan(R),). Mc Auley): A 10-fold dilution will result in a neglible change in the p H ( ~ 0.3). -------------------------------------------------------------------------------- Background information: Source: Action needed to prevent serious tissue injury with IV promethazine. Promethazine Rx. Brand and Other NamesPhenergan, Phenadoz. 25-50 mg IV/IM/PO/PR combined with reduced doses of analgesics and atropinelike drugs.

Medication and IV Administration NCLEX 3000 - Quizlet Problem: Promethazine (PHENERGAN) injection is a commonly used product that possesses antihistamine, sedative, anti-motion sickness, and antiemetic effects. Start studying Medication and IV Administration NCLEX 3000. Learn vocabulary, terms, and more with flashcards, games, and other study tools.

Phenergan Injection - FDA prescribing information, side effects and. Sedation Confusion Disorientation Blurred vision Hallucinations Dystonias Catatonic states Euphoria Excitation Extrapyramidal symptoms Tachycardia Bradycardia Leukopenia (rare) Agranulocytosis (rare) Obstructive jaundice Photosensitivity Dry mouth Angioneurotic edema Tardive dyskinesia Urticaria Xerostomia Impotence Urinary retention IV administration can cause severe tissue injury, including burning, gangrene, or thrombopebitis, necessitating fasciotomy, skin graft, or amputation Severe tissue injury can occur from perivascular extravasation, unintentional intra-arterial injection, and intraneuronal or perineuronal infiltration Deep IM injection is preferred method of administration Intra-arterial and SC administration are contraindicated 25 mg/m L product may be administered by deep IM injection or IV infusion (at rate not to exceed 25 mg/min through flowing IV tubing) Monitor for sns and symptoms of potential tissue injury including burning or pain at site of injection, pebitis, swelling, and blistering Discontinue IV infusion immediately if patient complains of pain during injection Respiratory fatalities reported with use in children Use caution in asthma, hepatic impairment, peptic ulcer disease, respiratory impairment, bone marrow suppression, anaphylaxis in susceptible individuals May impair ability to drive or perform hazardous tasks May impair core body temperature regulation; caution when taking medications with anticholinergic effects, heat exposure, or strenuous exercise Depresses hypothalamic thermoregulatory mechanism; exposure to extreme temperatures may cause hypo- or hyperthermia May alter cardiac conduction (life-threatening arrhythmias reported) Antiemetic effect may obscure toxicity of chemotherapeutic drugs Monitor closely in patients with cardiovascular disease, hepatic impairment, Reye syndrome, or history of sleep apnea Has anticholinergic effects; use with caution in patients with decreased gastrointestinal motility or obstructions (partial or comlete), urinary retention, urinary obstructions, xerostomia, BPH, or visual problems May cause extrapyramidal symptoms including pseudoparkinsonism, acute dystonic reactions, tardive dyskinesia, and akathisia Neuroleptic malnant syndrome reported with use; monitor for fever, muscle ridity and/or autonomic instability, or mental status changes May cause orthostatic hypotension; use caution in patients at risk of experiencing hypotensive episodes (cardiovascular disease, cerebrovascular disease, hypovolemia or taking medications that may predispose to bradycardia or hypotension) May cause photosensitivity Pyloroduodenal obstruction, stenosing peptic ulcer disease, bladder neck obstruction Anticholinergic effects of promethazine may exacerbate condition in patients with narrow-angle glaucoma or myasthenia gravis Bioavailability: 25% (PO/PR) Onset (antihistaminic effect): 3-5 min (IV); 20 min (IM/PO/PR) Peak serum time: 6.7-8.6 hr (suppositories); 4.4 hr (syrup) Duration: PO (motion sickness), 4-6 hr; IV (nausea and vomiting), 4-6 hr; up to 12 hr Solution: Compatible with most common solvents Additive: Amikacin, ascorbic acid injection, coroquine, hydromorphone, netilmicin, vitamins B and C Syringe (partial list): Atropine, diphenhydramine, fentanyl, meperidine, morphine sulfate(? ) The above information is provided for general informational and educational purposes only. Phenergan Injection official prescribing information for healthcare professionals. Due to the risks of intravenous injection, the preferred route of administration of. no greater than 25 mg per mL and at a rate not to exceed 25 mg per minute.

I. V. ADMINISTRATION GUIDELINES All IV meds must be. ) Y-site (partial list): Ciprofloxacin, cisplatin, cladribine, cyclophosphamide, cytarabine, fluconazole, gemcitabine, linezolid, teniposide Additive: Aminophylline, coramphenicol, corothiazide, floxacillin, furosemide, heparin, hydrocortisone sodium succinate, methohexital, penicillin G potassium (incompatible at promethazine 250 mg/L and penicillin 20 million units/L; may be compatible at lower concentrations), penicillin G sodium, pentobarbital, phenobarbital, thiopental Syringe: Cefotetan, coroquine, diatrizoate sodium 75%, diatrizoate meglumine/diatrizoate sodium, dimenhydrinate, heparin, iodipamide, iothalamate, ketorolac tromethamine, nalbuphine(? ), methotrexate, piperacillin/tazobactam, potassium coride(? Individual plans may vary and formulary information changes. I. V. ADMINISTRATION GUIDELINES All IV meds must be administered by IV pump Medication Dose Push min. Diluent Amount Over min. Remarks Category

Global Dealer Centre Food and Drug Administration (FDA) in 1951, promethazine (Phenergan) is a medication in common use today. Global - Public WebSites. live casinos reviews livedealercasino. Global Furniture Global Contract GLOBALcare


Iv infusion rate of phenergan:

Rating: 95 / 100

Overall: 90 Rates
Опубликовано в